Abbott agrees to settle DOJ lawsuit over baby formula plant contamination
Abbott Laboratories will pay $385 million to settle allegation related to how it operated a manufacturing plant tied to contaminated powdered baby formula suspected of causing infant deaths. Contamination led to the nation's largest formula facility being shuttered temporarily in 2022, triggering a recall of several infant formula brands, including Similac, exacerbating existing supply chain...
Covered in this story
Dalsna Finance is currently tracking 48 stories mentioning Abbott Laboratories, the earliest published 21 Mar 2026.
Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.